Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel prognostic matrisome-related gene signature of head and neck squamous cell carcinoma. | Front Cell Dev Biol | 2022 | 36081907 | PubTator, text mining | PubMed |
| Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells. | Cancers (Basel) | 2022 | 36077669 | PubTator, text mining | PubMed |
| Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 36077638 | PubTator, text mining | PubMed |
| Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | 36077637 | PubTator, text mining | PubMed |
| ISGylation of EMD promotes its interaction with PDHA to inhibit aerobic oxidation in lung adenocarcinoma. | J Cell Mol Med | 2022 | 36071546 | PubTator, text mining | PubMed |
| Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy. | Cancer Cell Int | 2022 | 36064367 | PubTator, text mining | PubMed |
| Association of FLG mutation with tumor mutation load and clinical outcomes in patients with gastric cancer. | Front Genet | 2022 | 36046250 | PubTator, text mining | PubMed |
| Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients. | Evid Based Complement Alternat Med | 2022 | 36034941 | PubTator, text mining | PubMed |
| Identification of SOX18 as a New Gene Predisposing to Congenital Heart Disease. | Diagnostics (Basel) | 2022 | 36010266 | PubTator, text mining | PubMed |
| Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer. | Cancer Sci | 2022 | 35997524 | PubTator, text mining | PubMed |
| Transcriptional and genetic alterations of cuproptosis-related genes correlated to malignancy and immune-infiltrate of esophageal carcinoma. | Cell Death Discov | 2022 | 35995782 | PubTator, text mining | PubMed |
| Identification of the alpha linolenic acid metabolism-related signature associated with prognosis and the immune microenvironment in nasopharyngeal carcinoma. | Front Endocrinol (Lausanne) | 2022 | 35992141 | PubTator, text mining | PubMed |
| Plasma cells arise from differentiation of clonal lymphocytes and secrete IgM in Waldenström macroglobulinemia. | iScience | 2022 | 35992066 | PubTator, text mining | PubMed |
| New feature extraction from phylogenetic profiles improved the performance of pathogen-host interactions. | Front Cell Infect Microbiol | 2022 | 35982784 | PubTator, text mining | PubMed |
| Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity. | PLoS One | 2022 | 35976950 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic and Expression Data Identified Potential Markers for Predicting Prognosis and Immune Response in CRC. | Genet Res (Camb) | 2022 | 35975176 | PubTator, text mining | PubMed |
| Ryanodine receptor (RYR) mutational status correlates with tumor mutational burden, age and smoking status and stratifies non-small cell lung cancer patient prognosis. | Transl Cancer Res | 2022 | 35966320 | PubTator, text mining | PubMed |
| Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer. | Transl Cancer Res | 2022 | 35966309 | PubTator, text mining | PubMed |
| A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma. | Cells | 2022 | 35954243 | PubTator, text mining | PubMed |
| TTN as a candidate gene for distal arthrogryposis type 10 pathogenesis. | J Genet Eng Biotechnol | 2022 | 35951140 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=27